Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes

COMMENTED

Further Publications Dermatology

Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

★ 2 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet

Rosenstock J, Wysham C, Frías JP, Kaneko S, Lee CJ, Fernández Landó L, Mao H, Cui X, Karanikas CA, Thieu VT

doi: 10.1016/S0140-6736(21)01324-6

Thyroid and Islet Autoantibodies Predict Autoimmune Thyroid Disease at Type 1 Diabetes Diagnosis

J Clin Endocrinol Metab.

Jonsdottir B, Larsson C, Carlsson A, Forsander G, Ivarsson SA, Lernmark Å, Ludvigsson J, Marcus C, Samuelsson U, Örtqvist E, Larsson HE; Better Diabetes Diagnosis Study Group

doi: 10.1210/jc.2016-2335.

T Cells

Reduced PD-1 expression on circulating follicular and conventional FOXP3⁺ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children

Clin Immunol.

Vecchione A, Gerosa J, Di Fonte R, Jofra T, Pia CM, Napoleone V, Ippolito E, Galvani G, Ragogna F, Stabilini A, Bianconi E, Grogan P, Bonura C, Bonfanti R, Frontino G, Nano R, Melzi R, De Pellegrin M, Laurenzi A, Meschi F, Barera G, Rigamonti A, Indirli R, Bosi E, Piemonti L, Aiuti A, Battaglia M, Fousteri G

doi: 10.1016/j.clim.2019.108319.

Immunotherapy

Novel immunotherapy strategies for hepatobiliary cancers

Immunotherapy.

DeLeon TT, Zhou Y, Nagalo BM, Yokoda RT, Ahn DH, Ramanathan RK, Salomao MA, Aqel BA, Mahipal A, Bekaii-Saab TS, Borad MJ

doi: 10.2217/imt-2018-0024.

Further Publications Dermatology

Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial

Lancet

Visser MM, Charleer S, Fieuws S, De Block C, Hilbrands R, Van Huffel L, Maes T, Vanhaverbeke G, Dirinck E, Myngheer N, Vercammen C, Nobels F, Keymeulen B, Mathieu C, Gillard P

doi: 10.1016/S0140-6736(21)00789-3

Immunotherapy

Characterization of Vibrio cholerae neuraminidase as an immunomodulator for novel formulation of oral allergy immunotherapy

Clin Immunol.

Diesner SC, Bergmayr C, Wang XY, Heiden D, Exenberger S, Roth-Walter F, Starkl P, Ret D, Pali-Schöll I, Gabor F, Untersmayr E

doi: 10.1016/

Allergic Diseases

Modulation of CRTh2 expression on allergen-specific T cells following peptide immunotherapy

Allergy.

Rudulier CD, Tonti E, James E, Kwok WW, Larché M

doi: 10.1111/all.13867.

The tumour glyco-code as a novel immune checkpoint for immunotherapy

Nat Rev Immunol.2018 Mar;18(3):204-211.doi: 10.1038/nri.2018.3.

RodrÍguez E, Schetters STT, van Kooyk Y

doi: 10.1038/nri.2018.3.

Psoriatic Arthritis

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study

Rheumatology (Oxford).

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N; PROMPT study group

doi: 10.1093/rheumatology/key286.

Related content